Hepatitis C Market is Expected to Drive Growth at 14.2% By 2032
13 juin 2023 02h32 HE
|
Precedence Research
Ottawa, June 13, 2023 (GLOBE NEWSWIRE) -- Latest Research Study on “Hepatitis C Market (By Drug Class: HCV Protease Inhibitors, HCV Polymerase Inhibitors, HCV NSSA Inhibitors, Combination Therapy,...